Search Results for:
-
Study Reveals How Synapses Stockpile Neurotransmitters
Nils Brose, director of the department of molecular neurobiology at the Max Planck Institute for Experimental Medicine in Göttingen, Germany, told BioWorld International: "We had already shown in 2004 how this process occurred in cultured nerve cells, but some neuroscientist colleagues were skeptical at that time about whether the same process also played a role in real synapses in the intact mammalian brain...Lipstein, a postdoctoral scientist in Brose's lab, told BioWorld International: "ThisBy Sharon Kingman | BioWorld International | Wednesday, June 19, 2013 -
Elan Up for Sale as Investors Reject Management, Royalty
It does make you wonder whether the shareholders have shot themselves in the foot here," Nick Turner, analyst at Mirabaud Securities, in London, told BioWorld InternationalBy Cormac Sheridan | BioWorld International | Wednesday, June 19, 2013 -
Campaign to Boost 'RAIT' of Clinical Data Transparency
every file has something in there that is commercially confidential," he told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 19, 2013 -
XO1 Cracks Coagulation Conundrum, Raises $11M
The field, almost simultaneously with this discovery, is beginning to figure out that it's a two-step process," Grainger told BioWorld International...The fund aims to attenuate risk by putting cash into small companies that have only one or two assets, reducing the amount of money that goes into building corporate infrastructure and putting the focus on finding out if the molecules work or not. (See BioWorld International, Oct. 17, 2013.)By Catherine Shaffer | BioWorld International | Wednesday, June 19, 2013 -
Biolinerx Teams with Jiangsu for Hepatitis C Drug in China
We believe it is a market with enormous potential, and we were looking to collaborate with a leading Chinese pharmaceutical company with the goal of advancing the development specifically in the Chinese market," Biolinerx CEO Kinneret Savitsky told BioWorld InternationalBy Shannon Ellis | BioWorld International | Wednesday, June 19, 2013 -
Valneva Raising $53M in Post-Merger Rights Issue
We are only to a very limited extent in control of our destiny," Valneva President and CEO Thomas Lingelbach told BioWorld InternationalBy Cormac Sheridan | BioWorld International | Wednesday, June 19, 2013 -
Astrazeneca Investing in New R&D Center in Cambridge, UK
It was a difficult decision for the organization because of the rich heritage of Alderley Park," he told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 19, 2013 -
Kael-Gemvax Forging Ahead Despite Cancer Vaccine Failure
The company is pursuing and continues to develop the drug," she told BioWorld International...he told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 19, 2013 -
XO1 Cracks Coagulation Conundrum, Raises $11M
The fund aims to attenuate risk by putting cash into small companies that have only one or two assets, reducing the amount of money that goes into building corporate infrastructure and putting the focus on finding out if the molecules work or not. (See BioWorld International, Oct. 17, 2013.)By Catherine Shaffer | BioWorld Today | Monday, June 17, 2013 -
Decision Time Looms for Elan, Royalty in Bitter Takeover Battle
I think it's quite compelling," Richard Parkes, analyst at Deutsche Bank in London, told BioWorld InternationalBio Perspectives | Wednesday, June 12, 2013 -
Beigene Inks $233M Deal with Merck for Cancer Drug
First, the preclinical development was fast: less than 2.5 years from the beginning of bench science, Beigene CEO John V. Oyler told BioWorld InternationalBy Larry Schuster | BioWorld International | Wednesday, June 12, 2013 -
Autifony Starts Phase I Work in Hearing Loss, Tinnitus
Attracting Pfizer Venture Investments has benefits beyond the cash investment," he told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 12, 2013 -
Scottish Start-up UB Pharma to Deliver UPS Drug Targets
chemical entities," Wilkie told BioWorld International...There's been huge investment and now it's ready to commercialize," he told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 12, 2013 -
Decision Time Looms for Elan, Royalty in Bitter Takeover Battle
I think it's quite compelling," Richard Parkes, analyst at Deutsche Bank in London, told BioWorld InternationalBy Cormac Sheridan | BioWorld International | Wednesday, June 12, 2013 -
Discovery of the Missing Link Points Way to Malaria Vaccine
Thomas Lavstsen, assistant professor at the Centre for Medical Parasitology at the University of Copenhagen, told BioWorld International: "We have found the receptor to which the parasite proteins bind during the development of severe malaria in childrenBy Sharon Kingman | BioWorld International | Wednesday, June 12, 2013 -
U.S. Biopharma Firms Hit by Cyber Attacks from China
groups," senior threat analyst Laura Galante told BioWorld InternationalBy Shannon Ellis | BioWorld International | Wednesday, June 12, 2013 -
Morphosys, GSK Ink $586M Pact for MOR103 in RA, MS
Some 60 percent of the company's institutional investors are U.S.-based, Morphosys CEO Simon Moroney told BioWorld International, whereas only 5 percent of its institutional investors are GermanBio Perspectives | Wednesday, June 5, 2013 -
Neuroblastoma Discovery May Lead to Wider Cancer Treatment
Marie Arsenian Henriksson, professor of molecular tumor biology at the Karolinska Institute in Stockholm, Sweden, told BioWorld International: "There is an urgent need for new therapies for neuroblastomaBy Sharon Kingman | BioWorld International | Wednesday, June 5, 2013 -
Morphosys, GSK Ink $586M Pact for MOR103 in RA, MS
Some 60 percent of the company's institutional investors are U.S.-based, Morphosys CEO Simon Moroney told BioWorld International, whereas only 5 percent of its institutional investors are GermanBy Cormac Sheridan | BioWorld International | Wednesday, June 5, 2013 -
Bergenbio's AXL-Kinase Inhibition Potential Is Broad
They are obviously satisfied with our progress, with the prospect of a significant value inflection in the near term," Richard Godfrey, CEO, told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, June 5, 2013
Category
Current Filters
- xBioWorld International
Related Keywords
Categories
- x BioWorld International (5413)
- x BioWorld Insight (594)
- x BioWorld Today (335)
- x Bio Perspectives (195)
- x State of the Industry Report (47)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.